AAC Holdings, Inc. (AAC) Receives $17.50 Consensus PT from Analysts

Shares of AAC Holdings, Inc. (NYSE:AAC) have been assigned an average recommendation of “Buy” from the six brokerages that are presently covering the stock, Marketbeat Ratings reports. Four analysts have rated the stock with a hold recommendation, one has issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $15.33.

A number of equities analysts have commented on the stock. Cantor Fitzgerald assumed coverage on shares of AAC Holdings in a research report on Wednesday. They set an “overweight” rating and a $11.00 price objective for the company. Zacks Investment Research raised shares of AAC Holdings from a “sell” rating to a “hold” rating in a research report on Wednesday. Finally, Mizuho reduced their price objective on shares of AAC Holdings from $9.00 to $6.00 and set a “neutral” rating for the company in a research report on Tuesday, May 30th.

COPYRIGHT VIOLATION NOTICE: “AAC Holdings, Inc. (AAC) Receives $17.50 Consensus PT from Analysts” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this news story on another publication, it was stolen and reposted in violation of United States & international copyright laws. The original version of this news story can be accessed at https://www.com-unik.info/2017/08/12/aac-holdings-inc-aac-receives-17-50-consensus-pt-from-analysts.html.

Shares of AAC Holdings (AAC) traded up 2.85% during mid-day trading on Wednesday, reaching $8.67. 75,340 shares of the company’s stock were exchanged. The stock’s 50-day moving average is $6.98 and its 200-day moving average is $7.49. The stock’s market cap is $208.60 million. AAC Holdings has a 52-week low of $5.99 and a 52-week high of $21.45.

AAC Holdings (NYSE:AAC) last released its quarterly earnings data on Wednesday, August 2nd. The company reported $0.26 EPS for the quarter, topping the Zacks’ consensus estimate of $0.14 by $0.12. AAC Holdings had a negative net margin of 1.55% and a positive return on equity of 10.70%. The firm had revenue of $78.04 million during the quarter, compared to analysts’ expectations of $73.40 million. During the same period in the previous year, the business posted $0.18 earnings per share. The company’s revenue for the quarter was up 9.1% compared to the same quarter last year. On average, equities analysts expect that AAC Holdings will post $0.54 EPS for the current year.

Large investors have recently made changes to their positions in the stock. Woodmont Investment Counsel LLC boosted its stake in shares of AAC Holdings by 10.0% in the second quarter. Woodmont Investment Counsel LLC now owns 45,226 shares of the company’s stock worth $313,000 after buying an additional 4,130 shares during the last quarter. Northern Trust Corp boosted its stake in shares of AAC Holdings by 4.6% in the second quarter. Northern Trust Corp now owns 128,741 shares of the company’s stock worth $893,000 after buying an additional 5,709 shares during the last quarter. Nationwide Fund Advisors boosted its stake in shares of AAC Holdings by 116.4% in the second quarter. Nationwide Fund Advisors now owns 34,414 shares of the company’s stock worth $238,000 after buying an additional 18,511 shares during the last quarter. Alliancebernstein L.P. boosted its stake in shares of AAC Holdings by 3.8% in the second quarter. Alliancebernstein L.P. now owns 20,600 shares of the company’s stock worth $143,000 after buying an additional 760 shares during the last quarter. Finally, Rhumbline Advisers boosted its stake in shares of AAC Holdings by 38.5% in the second quarter. Rhumbline Advisers now owns 21,719 shares of the company’s stock worth $151,000 after buying an additional 6,040 shares during the last quarter. 48.02% of the stock is owned by institutional investors.

AAC Holdings Company Profile

AAC Holdings, Inc is a provider of inpatient and outpatient substance abuse treatment services for individuals with drug and alcohol addiction. The Company performs drug testing and diagnostics laboratory services and provides physician services to its clients. As of June 30, 2016, the Company operated 12 residential substance abuse treatment facilities located throughout the United States, focused on delivering clinical care and treatment solutions across 1,139 beds, which includes 636 licensed detoxification beds, and 18 standalone outpatient centers.

What are top analysts saying about AAC Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for AAC Holdings Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit